The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters
- PMID: 7812182
The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters
Abstract
A common feature of the Epstein-Barr virus (EBV)-associated malignancy, Burkitt's lymphoma, is chromosomal translocation affecting the c-myc oncogene. We report here that an EBV immediate-early (IE) protein, BRLF1 (R), transactivates the murine and human c-myc promoters. The R transactivator enhances expression from transiently transfected murine and human c-myc promoters as determined both at the CAT reporter and at the mRNA level. Transactivation of the human c-myc promoter by R occurs in several different cell lines, and this effect is reporter-gene independent. Both the P1 and P2 c-myc promoters can be activated by the EBV R IE protein, although the R-induced transactivation of P1 is greater than P2. The portion of the human c-myc promoter from -228 to -63 (relative to the P1 mRNA start site) is necessary, but not sufficient, for transactivation by R in the Louckes B-cell line. Binding of the R protein directly to the c-myc promoter could not be demonstrated, suggesting that the effect of R on c-myc activity occurs by an indirect mechanism. The ability of an EBV protein to activate c-myc expression is likely to facilitate productive viral infection and is also potentially relevant in the genesis of EBV-associated lymphomas.
Similar articles
-
Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.Virology. 1998 Nov 10;251(1):187-97. doi: 10.1006/viro.1998.9396. Virology. 1998. PMID: 9813214
-
The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.Med Sci Monit. 2003 Jan;9(1):HY1-9. Med Sci Monit. 2003. PMID: 12552250
-
Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.Oncogene. 1993 Jun;8(6):1437-47. Oncogene. 1993. PMID: 8502472
-
c-MYC impairs immunogenicity of human B cells.Adv Cancer Res. 2007;97:167-88. doi: 10.1016/S0065-230X(06)97007-9. Adv Cancer Res. 2007. PMID: 17419945 Review.
-
The association of c-myc rearrangements with specific types of human non-Hodgkin's lymphomas.Leuk Lymphoma. 1992 Aug;7(5-6):371-6. doi: 10.3109/10428199209049793. Leuk Lymphoma. 1992. PMID: 1493439 Review.
Cited by
-
Epstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoter.J Virol. 2007 May;81(9):4837-47. doi: 10.1128/JVI.02448-06. Epub 2007 Feb 14. J Virol. 2007. PMID: 17301127 Free PMC article.
-
Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene.J Virol. 2000 Sep;74(18):8623-34. doi: 10.1128/jvi.74.18.8623-8634.2000. J Virol. 2000. PMID: 10954564 Free PMC article.
-
A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10866-71. doi: 10.1073/pnas.95.18.10866. Proc Natl Acad Sci U S A. 1998. PMID: 9724796 Free PMC article.
-
Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation.J Virol. 2001 Jul;75(13):6228-34. doi: 10.1128/JVI.75.13.6228-6234.2001. J Virol. 2001. PMID: 11390628 Free PMC article.
-
Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.J Virol. 2021 Jun 10;95(13):e0019221. doi: 10.1128/JVI.00192-21. Epub 2021 Jun 10. J Virol. 2021. PMID: 33853968 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous